BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3263204)

  • 1. Effect of phytohemagglutinin and interleukin-2 on malignant and nonmalignant B and T lymphocytes.
    Porwit A; Panayotides P; Wasserman J; Reizenstein P
    Cancer Detect Prev; 1988; 12(1-6):91-6. PubMed ID: 3263204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals.
    Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M
    Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
    Vose BM; Bonnard GD
    J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased production of interleukin-6 by T lymphocytes from patients with multiple myeloma.
    Lapeña P; Prieto A; Garcia-Suarez J; Reyes E; San Miguel J; Jorda J; Alvarez-Mon M
    Exp Hematol; 1996 Jan; 24(1):26-30. PubMed ID: 8536788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-galactosidase transduced T lymphocytes: a comparison between stimulation by either PHA and IL-2 or a mixed lymphocyte reaction.
    Di Ianni M; Casciari C; Ciurnelli R; Fulvi A; Bagnis C; Lucheroni F; Falzetti F; Mannoni P; Martelli MF; Tabilio A
    Haematologica; 1996; 81(5):410-7. PubMed ID: 8952153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates.
    Ueda M; Joshi ID; Dan M; Uberti JP; Chou TH; Sensenbrenner LL; Lum LG
    Transplantation; 1993 Aug; 56(2):351-6. PubMed ID: 8356589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressed in vitro T cell responses concomitant with augmented interleukin-2 responses by lymphocytes from cancer patients following in vivo treatment with interleukin-2.
    Hank JA; Sosman JA; Kohler PC; Bechhofer R; Storer B; Sondel PM
    J Biol Response Mod; 1990 Feb; 9(1):5-14. PubMed ID: 2181071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased basal production of interleukin-10 by peripheral blood mononuclear cells in human alveolar echinococcosis.
    Godot V; Harraga S; Deschaseaux M; Bresson-Hadni S; Gottstein B; Emilie D; Vuitton DA
    Eur Cytokine Netw; 1997 Dec; 8(4):401-8. PubMed ID: 9459621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 2 (IL 2) relationships with the cancer-related immunodeficiency: in vitro response to exogenous IL 2 by PHA-activated and non PHA-activated peripheral blood mononuclear cells from cancer patients.
    Mantovani G; Coiana A; Massidda A; Proto E; Floris C; Macciò A; Pusceddu G; Del Giacco GS
    Diagn Clin Immunol; 1987; 5(2):104-11. PubMed ID: 3497733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competition of IL-1 and IL-1ra determines lymphocyte response to delayed stimulation with PHA.
    Dabrowski MP; Stankiewicz W; Płusa T; Chciałowski A; Szmigielski S
    Mediators Inflamm; 2001 Jun; 10(3):101-7. PubMed ID: 11545246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of human T cell response to mitogens: IL 2 induces IL 2 receptor expression and proliferation but not IL 2 synthesis in PHA-stimulated T cells.
    Katzen D; Chu E; Terhost C; Leung DY; Gesner M; Miller RA; Geha RS
    J Immunol; 1985 Sep; 135(3):1840-5. PubMed ID: 3926887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoteichoic acid derived from Enterococcus faecalis modulates the functional characteristics of both normal peripheral blood leukocytes and native human acute myelogenous leukemia blasts.
    Bruserud Ø; Wendelbo Ø; Paulsen K
    Eur J Haematol; 2004 Nov; 73(5):340-50. PubMed ID: 15458513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The expression of CD25 in phytohemagglutinin- or interleukin-2-stimulated human peripheral blood lymphocytes].
    Zenin VV; Aksenov ND; Shatrova AN; Marakhova II
    Tsitologiia; 2009; 51(6):506-10. PubMed ID: 19637754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and functional analysis of peripheral blood mononuclear cells in generalised aggressive and chronic periodontitis patients.
    Emingil G; Karaarslan F; Keskinoğlu A; Coker I; Atilla G
    J Int Acad Periodontol; 2001 Oct; 3(4):87-94. PubMed ID: 12666947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of phorbol myristate acetate (PMA) and ionophore A23187 on interleukin-2 levels and proliferation of activated T lymphocytes from patients with lepromatous leprosy.
    Alfaro-Bustamante F; Ramirez-Flores G; Gonzalez-Mendoza A; Islas-Rodriguez A; Fafutis-Morris M
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):73-9. PubMed ID: 9207756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
    Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
    Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity of B leukemic lymphocytes of patients with chronic lymphocytic leukemia to PWM and PHA.
    Isaković K; Lenert G
    Blood Cells; 1987; 12(2):355-64. PubMed ID: 3497681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro proliferative and differentiated responses of lymphoma cells to PHA and IL-4 in a patient with intermediate lymphocytic lymphoma.
    Ishiyama T; Watanabe K; Yajima K; Akimoto Y; Tomoyasu S; Tsuruoka N; Ota H
    Int J Hematol; 1992 Aug; 56(1):41-50. PubMed ID: 1391805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of natural killer cells with lytic activity against autologous blasts from adult and pediatric acute lymphoid leukemia patients in complete hematologic remission.
    Torelli GF; Guarini A; Maggio R; Alfieri C; Vitale A; Foà R
    Haematologica; 2005 Jun; 90(6):785-92. PubMed ID: 15951291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients.
    Wang X; Zheng J; Liu J; Yao J; He Y; Li X; Yu J; Yang J; Liu Z; Huang S
    Eur J Haematol; 2005 Dec; 75(6):468-76. PubMed ID: 16313258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.